Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
HAIFA, Israel, Oct. 07, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]
Caledonia Mining Corporation Plc: Solar power project update
ST HELIER, Jersey, Oct. 07, 2020 (GLOBE NEWSWIRE) — Further to the announcement on September 4, 2020 regarding Caledonia Mining […]
TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 07, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage […]
TSX News -
Interfor to Announce Third Quarter Results on November 5, 2020
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) —INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) will release its third […]
TSX News -
CAPREIT Announces Timing of Third Quarter 2020 Results & Conference Call
TORONTO, Oct. 06, 2020 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today it will […]
Fura Gems Shareholders Approve Going Private Transaction
TORONTO, Oct. 06, 2020 (GLOBE NEWSWIRE) — Fura Gems Inc. (“Fura” or the “Company”) (TSXV: Fura, OTC: FUGMF and FRA: […]
Brookfield Real Assets Income Fund Inc. Announces Corrected Ex-Date for November Monthly Distribution
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) — Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) is announcing […]
NextGen Acquisition Corporation Announces Pricing of $350 Million Initial Public Offering
BOCA RATON, FL, Oct. 06, 2020 (GLOBE NEWSWIRE) — NextGen Acquisition Corporation (the “Company”) announced today that it priced its […]
Aerojet Rocketdyne’s New State-of-the-Art Large Solid Rocket Motor Facility Open for Operations
CAMDEN, Ark., Oct. 06, 2020 (GLOBE NEWSWIRE) — Aerojet Rocketdyne’s new large solid rocket motor manufacturing facility is officially open […]
Arvinas to Present at the 3rd Annual Targeted Protein Degradation Summit
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
